Myocardial Recovery, Metabolism, and Structure after Cardiac Arrest with Cardioplexol

 

 Buy Article Permissions and Reprints All articles of this category

Abstract

Objectives Clinical studies indicate encouraging cardioprotective potential for Cardioplexol. Its cardioprotective capacities during 45 minutes of ischemia compared with pure no-flow ischemia or during 90 minutes of ischemia compared with Calafiore cardioplegia were investigated experimentally.

Methods Forty-four rat hearts were isolated and inserted into a blood-perfused pressure-controlled Langendorff apparatus. In a first step, cardiac arrest was induced by Cardioplexol or pure no-flow ischemia lasting 45 minutes. In a second step, cardiac arrest was induced by Cardioplexol or Calafiore cardioplegia lasting 90 minutes. For both experimental steps, cardiac function, metabolic parameters, and troponin I levels were evaluated during 90 minutes of reperfusion. At the end of reperfusion, hearts were fixed, and ultrastructural integrity was examined by electron microscopy.

Results Step 1: after 90 minutes of reperfusion, hearts exposed to Cardioplexol had significantly higher left ventricular developed pressure (CP-45ˊ: 74%BL vs. no-flow-45ˊ: 45%BL; p = 0.046) and significantly better maximal left ventricular relaxation (CP-45ˊ: 84%BL vs. no-flow-45ˊ: 51%BL; p = 0.012). Oxygen consumption, lactate production, and troponin levels were similar in both groups. Step 2: left ventricular developed pressure was lower (22 vs. 48% of BL; p = 0.001) and coronary flow was lower (24 vs. 53% of BL; p = 0.002) when Cardioplexol was used compared with Calafiore cardioplegia. Troponin I levels were significantly higher under Cardioplexol (358.9 vs. 106.1 ng/mL; p = 0.016).

Conclusion Cardioplexol significantly improves functional recovery after 45 minutes of ischemia compared with pure ischemia. However, Cardioplexol protects the myocardium from ischemia/reperfusion-related damage after 90 minutes of ischemia worse than Calafiore cardioplegia.

Presentation at Scientific Meetings

Preliminary results have been presented at the annual meeting of the DGTHG in February 2021. Additionally, results have been presented at the annual meeting of the DGTHG in February 2023.

Publication History

Received: 23 May 2023

Accepted: 10 July 2023

Article published online:
10 August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Tevaeara Stahel H, Barandun S, Kaufmann E. et al. Single-center experience with the combination of Cardioplexol™ cardioplegia and MiECC for isolated coronary artery bypass graft procedures. J Thorac Dis 2019; 11 (Suppl. 10) S1471-S1479
  CrossrefPubMedGoogle Scholar
• 2 Tschopp S, Eckstein F, Matt P. Low-volume cardioplegia and myocardial protection in coronary artery bypass graft surgery. Thorac Cardiovasc Surg 2019; 67 (06) 484-487
  Article in Thieme ConnectPubMedGoogle Scholar
• 3 Matt P, Arbeleaz E, Schwirtz G, Doebele T, Eckstein F. Low-volume, single-shot crystalloid cardioplegia is safe for isolated aortic valve replacement. Thorac Cardiovasc Surg 2012; 60 (05) 360-362
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Kairet K, Deen J, Vernieuwe L, De Bruyn A, Kalantary S, Rodrigus I. Cardioplexol, a new cardioplegic solution for elective CABG. J Cardiothorac Surg 2013; 8: 120
  CrossrefPubMedGoogle Scholar
• 5 Moh'd AF, Al-Odwan HT, Altarabsheh S, Makahleh ZM, Khasawneh MA. Predictors of aortic clamp time duration and intensive care unit length of stay in elective adult cardiac surgery. Egypt Heart J 2021; 73 (01) 92
  CrossrefPubMedGoogle Scholar
• 6 Koechlin L, Zenklusen U, Doebele T. et al. Clinical implementation of a novel myocardial protection pathway in coronary artery bypass surgery with minimal extracorporeal circulation. Perfusion 2019; 34 (04) 277-284
  CrossrefPubMedGoogle Scholar
• 7 Koechlin L, Rrahmani B, Gahl B. et al. Microplegia versus Cardioplexol® in coronary artery bypass surgery with minimal extracorporeal circulation: comparison of two cardioplegia concepts. Thorac Cardiovasc Surg 2020; 68 (03) 223-231
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Böning A, Hagmüller S, Heep M, Rohrbach S, Niemann B, Mühlfeld C. Is warm or cold Calafiore blood cardioplegia better? Hemodynamic, metabolic, and electron microscopic differences. Thorac Cardiovasc Surg 2014; 62 (08) 683-689
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Böning A, Rohrbach S, Kohlhepp L. et al. Differences in ischemic damage between young and old hearts–Effects of blood cardioplegia. Exp Gerontol 2015; 67: 3-8
  CrossrefPubMedGoogle Scholar
• 10 Follath F, Cleland JGF, Just H. et al; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360 (9328) 196-202
  CrossrefPubMedGoogle Scholar
• 11 Mühlfeld C, Nyengaard JR, Mayhew TM. A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovasc Pathol 2010; 19 (02) 65-82
  CrossrefPubMedGoogle Scholar
• 12 DiBona DR, Powell Jr WJ. Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ Res 1980; 47 (05) 653-665
  CrossrefPubMedGoogle Scholar
• 13 Mühlfeld C, Richter J. High-pressure freezing and freeze substitution of rat myocardium for immunogold labeling of connexin 43. Anat Rec A Discov Mol Cell Evol Biol 2006; 288 (10) 1059-1067
  CrossrefPubMedGoogle Scholar
• 14 Schmiedl A, Schnabel PA, Mall G. et al. The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling. Correlations during the course of myocardial global ischaemia. Virchows Arch A Pathol Anat Histopathol 1990; 416 (04) 305-315
  CrossrefPubMedGoogle Scholar
• 15 Doughty RN, Klein AL, Poppe KK. et al; Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators. Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Eur J Heart Fail 2008; 10 (08) 786-792
  CrossrefPubMedGoogle Scholar
• 16 Metkus TS, Suarez-Pierre A, Crawford TC. et al. Diastolic dysfunction is common and predicts outcome after cardiac surgery. J Cardiothorac Surg 2018; 13 (01) 67
  CrossrefPubMedGoogle Scholar
• 17 Garcia-Dorado D, Andres-Villarreal M, Ruiz-Meana M, Inserte J, Barba I. Myocardial edema: a translational view. J Mol Cell Cardiol 2012; 52 (05) 931-939
  CrossrefPubMedGoogle Scholar
• 18 Laine GA, Allen SJ. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991; 68 (06) 1713-1721
  CrossrefPubMedGoogle Scholar
• 19 Desai KV, Laine GA, Stewart RH. et al. Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol 2008; 294 (06) H2428-H2434
  CrossrefPubMedGoogle Scholar
• 20 Jennings RB, Sommers HM, Kaltenbach JP, West JJ. Electrolyte alterations in acute myocardial ischemic injury. Circ Res 1964; 14: 260-269
  CrossrefPubMedGoogle Scholar
• 21 Inserte J, Garcia-Dorado D, Ruiz-Meana M, Solares J, Soler J. The role of Na+-H+ exchange occurring during hypoxia in the genesis of reoxygenation-induced myocardial oedema. J Mol Cell Cardiol 1997; 29 (04) 1167-1175
  CrossrefPubMedGoogle Scholar
• 22 Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol 1977; 39 (07) 986-993
  CrossrefPubMedGoogle Scholar
• 23 Kingsley PB, Sako EY, Yang MQ. et al. Ischemic contracture begins when anaerobic glycolysis stops: a 31P-NMR study of isolated rat hearts. Am J Physiol 1991; 261 (2, Pt 2): H469-H478
  PubMedGoogle Scholar
• 24 Grossman W, Barry WH. Diastolic pressure-volume relations in the diseased heart. Fed Proc 1980; 39 (02) 148-155
  PubMedGoogle Scholar
• 25 Humphrey SM, Gavin JB, Herdson PB. The relationship of ischemic contracture of vascular reperfusion in the isolated rat heart. J Mol Cell Cardiol 1980; 12 (12) 1397-1406
  CrossrefPubMedGoogle Scholar
• 26 Flameng W, Lesaffre E, Vanhaecke J. Determinants of infarct size in non-human primates. Basic Res Cardiol 1990; 85 (04) 392-403
  CrossrefPubMedGoogle Scholar
• 27 Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993; 72 (19) 13G-21G
  CrossrefPubMedGoogle Scholar
• 28 Garcia-Dorado D, Théroux P, Elizaga J. et al. Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion. Cardiovasc Res 1987; 21 (07) 537-544
  CrossrefPubMedGoogle Scholar
• 29 Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia/reperfusion. Compr Physiol 2016; 7 (01) 113-170
  CrossrefPubMedGoogle Scholar
• 30 Jennings RB, Schaper J, Hill ML, Steenbergen Jr C, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985; 56 (02) 262-278
  CrossrefPubMedGoogle Scholar
• 31 Chambers DJ, Fallouh HB. Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion. Pharmacol Ther 2010; 127 (01) 41-52
  CrossrefPubMedGoogle Scholar
• 32 Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol 2011; 50 (06) 940-950
  CrossrefPubMedGoogle Scholar